ABT
Abbott Laboratories · $105.70 (+0.1%) · mkt cap $182.9B · P/E 34.2
91 hub catalysts across 9 sources · backtest → · ← Ticker Explorer
Analyst Ratings (Upgrades/Downgrades)FINRA Short VolumeU.S. House — Congressional TradesInsider Transactions (SEC Form 4)Financial News (Google News)FDA Approvals & RecallsSEC EDGAR FilingsU.S. Senate — Congressional TradesWikipedia Pageviews (Attention)
Signal summary
Signals divergeBullish and bearish forces are in conflict here — weigh both columns.
100▲ Bull-leanconviction from hub signals
Bullish factors
- Congress bought (3)
- FDA approval
- 1 analyst upgrade
Bearish factors
- Congress sold (6)
- Insiders net selling (12 vs 5)
Context (not directional): Short volume 1% of float-traded · News flow (42 recent) · Wikipedia attention spike
Signal mix for ABT
Which data feeds have fired on this name — hover a slice for counts.
Best strategy
2-yr backtest · by SharpeKeltner Channel Breakout has fit ABT best over 2 years (+23.3%, Sharpe 0.56). Historical/in-sample — walk-forward all 19 →
| # | Strategy | Return | Sharpe | Beats B&H |
|---|---|---|---|---|
| 1 | Keltner Channel Breakout | +23.3% | 0.56 | ✓ |
| 2 | Connors RSI(2) | +13.6% | 0.39 | ✓ |
| 3 | Momentum (rate-of-change) | +13.0% | 0.38 | ✓ |
Price — 1 year
daily closeInsider activity
5 open-market buysOfficers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.
| Date | Action | Insider | Shares | Value |
|---|---|---|---|---|
| 2026-05-07 | BUY | Stratton John G. | 2,000 | $174K |
| 2026-04-27 | BUY | Starks Daniel J | 10,000 | $927K |
| 2026-04-23 | BUY | Boudreau Philip P | 2,200 | $201K |
| 2026-03-02 | SELL | Salvadori Daniel Gesua Sive | 885 | $102K |
| 2026-03-02 | SELL | Mccoy John A. Jr | 585 | $68K |
| 2026-03-02 | SELL | Morrone Louis H | 1,144 | $132K |
| 2026-03-02 | SELL | Shroff Eric | 709 | $82K |
| 2026-03-02 | SELL | Cushman Elizabeth C | 263 | $30K |
| 2026-03-02 | SELL | Moreland Mary K | 613 | $71K |
| 2026-02-04 | BUY | Starks Daniel J | 10,000 | $1.1M |
| 2026-01-23 | BUY | Ford Robert B. | 18,800 | $2.0M |
| 2025-11-25 | SELL | Shroff Eric | 1,586 | $203K |
| 2025-08-08 | SELL | Boudreau Philip P | 5,550 | $747K |
| 2025-04-30 | SELL | Blount Sally E | 2,600 | $337K |
| 2025-03-07 | SELL | Earnhardt Lisa D | 91,367 | $12.2M |
| 2025-03-03 | SELL | Mccoy John A. Jr | 562 | $78K |
| 2025-03-03 | SELL | Shroff Eric | 562 | $78K |
Analyst ratings
live · 2 changes| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| 2026-07-01 | Initiated | Baird | Outperform |
| 2026-01-29 | Upgrade | Freedom Broker | Hold → Buy |
Catalyst timeline
91 hub signals| Date | Source | Event | Entity | Value | |
|---|---|---|---|---|---|
| 2026-08-01 | FDA Approvals & Recalls | FDA Approval | FDA approved Esprit BTK Everolimus Eluting Resorbable Scaffold System — ABBOTT MEDICAL | approval | source ↗ |
| 2026-08-01 | FDA Approvals & Recalls | FDA Approval | FDA approved Volt PFA System — ABBOTT MEDICAL | approval | source ↗ |
| 2026-07-28 | Financial News (Google News) | News | $ABT stock is up 4% today. Here's what we see in our data. - Quiver Quantitative | 9 | source ↗ |
| 2026-07-27 | Financial News (Google News) | News | Abbott (ABT) Raised Its Profit Forecast. What’s Driving Its Growth? - Yahoo Finance | 8 | source ↗ |
| 2026-07-27 | FINRA Short Volume | Short Vol | ABT | 53% short | source ↗ |
| 2026-07-27 | FDA Approvals & Recalls | FDA Approval | FDA approved Navitor Transcatheter Aortic Valve Implantation System — ABBOTT MEDICAL | approval | source ↗ |
| 2026-07-25 | Financial News (Google News) | News | Abbott Laboratories (ABT) Could Be 14% Undervalued On Mixed Earnings And Growth Focus - simplywall.st | 7 | source ↗ |
| 2026-07-23 | Financial News (Google News) | News | Abbott Laboratories (ABT) Earnings Drew Fresh Attention, Is It Still Below Fair Value? - Yahoo Finance | 7 | source ↗ |
| 2026-07-23 | Financial News (Google News) | News | Abbott Laboratories (ABT) Earnings Drew Fresh Attention, Is It Still Below Fair Value? - Yahoo Finance | 5 | source ↗ |
| 2026-07-23 | Financial News (Google News) | News | Abbott Laboratories (ABT) Earnings Drew Fresh Attention, Is It Still Below Fair Value? - Yahoo Finance | 5 | source ↗ |
| 2026-07-22 | FDA Approvals & Recalls | FDA Approval | FDA approved Dorsal Root Ganglion (DRG) Implantable Pulse Generator (IPG) — ABBOTT MEDICAL | approval | source ↗ |
| 2026-07-18 | Financial News (Google News) | News | Abbott Stock: Bear Trap Over, With Richer Return Prospects (NYSE:ABT) - Seeking Alpha | 24 | source ↗ |
| 2026-07-16 | Financial News (Google News) | News | Abbott raises 2026 earnings outlook after second-quarter results beat expectations (ABT) - Yahoo Finance | 6 | source ↗ |
| 2026-07-16 | SEC EDGAR Filings | 8-K Event | ABBOTT LABORATORIES | source ↗ | |
| 2026-07-16 | Financial News (Google News) | News | Abbott raises 2026 earnings outlook after second-quarter results beat expectations (ABT) - Yahoo Finance | 20 | source ↗ |
| 2026-07-16 | Financial News (Google News) | News | Abbott raises 2026 earnings outlook after second-quarter results beat expectations (ABT) - Yahoo Finance | 26 | source ↗ |
| 2026-07-13 | FDA Approvals & Recalls | FDA Approval | FDA approved Epic Elite Mitral; Epic Elite Aortic; Epic Supra G3 valves — ABBOTT MEDICAL | approval | source ↗ |
| 2026-07-13 | Financial News (Google News) | News | Baird Initiates Coverage on Abbott Laboratories (ABT) Stock with Outperform Rating - Yahoo Finance | 6 | source ↗ |
| 2026-07-13 | FINRA Short Volume | Short Vol | ABT | 51% short | source ↗ |
| 2026-07-13 | Financial News (Google News) | News | Baird Initiates Coverage on Abbott Laboratories (ABT) Stock with Outperform Rating - Yahoo Finance | 8 | source ↗ |
| 2026-07-13 | Financial News (Google News) | News | Baird Initiates Coverage on Abbott Laboratories (ABT) Stock with Outperform Rating - Yahoo Finance | 3 | source ↗ |
| 2026-07-13 | Financial News (Google News) | News | Baird Initiates Coverage on Abbott Laboratories (ABT) Stock with Outperform Rating - Yahoo Finance | 8 | source ↗ |
| 2026-07-10 | Financial News (Google News) | News | Abbott (ABT) Stock Still Looks Cheap On Cash Flow And Earnings - simplywall.st | 5 | source ↗ |
| 2026-07-08 | U.S. House — Congressional Trades | Congress SELL | Hon. Rick Larsen | $1,001 - $15,000 | source ↗ |
| 2026-07-08 | Financial News (Google News) | News | Abbott Laboratories (ABT) Q1 Sales And Guidance Put Fair Value Back In Focus - Yahoo Finance | 6 | source ↗ |
| 2026-07-06 | FDA Approvals & Recalls | FDA Approval | FDA approved HeartMate 3 Left Ventricular Assist System (LVAS) — ABBOTT MEDICAL | approval | source ↗ |
| 2026-07-06 | FDA Approvals & Recalls | FDA Approval | FDA approved UltiPace Low Voltage LPA1231, Tendril Low Voltage 2088TC, Op — ABBOTT MEDICAL | approval | source ↗ |
| 2026-07-06 | FDA Approvals & Recalls | FDA Approval | FDA approved UltiPace Low Voltage LPA1231, Tendril Low Voltage 2088TC, Op — ABBOTT MEDICAL | approval | source ↗ |
| 2026-07-06 | FDA Approvals & Recalls | FDA Approval | FDA approved The AVEIR Leadless Pacemaker (LP) — ABBOTT MEDICAL | approval | source ↗ |
| 2026-07-05 | Financial News (Google News) | News | Abbott Laboratories Stock (ABT) Opinions on Recent FDA Approvals and Product Launches - Quiver Quantitative | 3 | source ↗ |
| 2026-07-05 | Financial News (Google News) | News | ABT Stock Quote Price and Forecast - CNN | 5 | source ↗ |
| 2026-07-04 | Financial News (Google News) | News | ABT, FIG, IP Stocks Fell To 52-Week Lows Today: What's Happening? - Stocktwits | 4 | source ↗ |
| 2026-07-03 | Wikipedia Pageviews (Attention) | Wiki Attention | Abbott Laboratories: 777 views/day (1.32x normal) | 1.3× attention | source ↗ |
| 2026-07-02 | Wikipedia Pageviews (Attention) | Wiki Attention | Abbott Laboratories: 777 views/day (1.33x normal) | 1.3× attention | source ↗ |
| 2026-07-01 | Financial News (Google News) | News | Abbott (ABT) director receives 363 stock equivalent units as board compensation - Stock Titan | 12 | source ↗ |
| 2026-07-01 | Analyst Ratings (Upgrades/Downgrades) | Analyst Initiated | Baird: Initiated (Outperform) | source ↗ | |
| 2026-06-29 | FDA Approvals & Recalls | FDA Approval | FDA approved Alinity m HR HPV Assay — Abbott Molecular, Inc. | approval | source ↗ |
| 2026-06-29 | Financial News (Google News) | News | Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo! Finance Canada | 12 | source ↗ |
| 2026-06-29 | Financial News (Google News) | News | Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo! Finance Canada | 5 | source ↗ |
| 2026-06-29 | Financial News (Google News) | News | Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo! Finance Canada | 10 | source ↗ |
| 2026-06-29 | FDA Approvals & Recalls | FDA Approval | FDA approved HeartMate II Left Ventricular Assist System (LVAS) — ABBOTT MEDICAL | approval | source ↗ |
| 2026-06-27 | Financial News (Google News) | News | Abbott Laboratories (ABT) Stock After Recent Rebound Is There Still Value Left - Yahoo Finance | 6 | source ↗ |
| 2026-06-27 | Financial News (Google News) | News | Abbott Laboratories (ABT) Stock After Recent Rebound Is There Still Value Left - Yahoo Finance | 6 | source ↗ |
| 2026-06-27 | Financial News (Google News) | News | Abbott Laboratories (ABT) Stock After Recent Rebound Is There Still Value Left - Yahoo Finance | 5 | source ↗ |
| 2026-06-25 | Financial News (Google News) | News | How An ALZpath Alzheimer’s Test Deal And Dividend Streak At Abbott (ABT) Has Changed Its Investment Story - simplywall.st | 8 | source ↗ |
| 2026-06-23 | Financial News (Google News) | News | Abbott Laboratories (ABT) Stock After 33% One-Year Slide Is The Market Overreacting - simplywall.st | 5 | source ↗ |
| 2026-06-22 | FDA Approvals & Recalls | FDA Approval | FDA approved Navitor TAVI System with Vision Technology — ABBOTT MEDICAL | approval | source ↗ |
| 2026-06-21 | Financial News (Google News) | News | Abbott Laboratories (ABT) Stock Could Be 24% Below Fair Value Before Earnings - simplywall.st | 4 | source ↗ |
| 2026-06-19 | Financial News (Google News) | News | Citi Believes Abbott (ABT) Shares are Undervalued Relative to Business Segments - Yahoo Finance | 2 | source ↗ |
| 2026-06-17 | Financial News (Google News) | News | Abbott (ABT) Share Value Potential Estimated at $99-$104 by Citi - GuruFocus | 4 | source ↗ |
| 2026-06-16 | U.S. House — Congressional Trades | Congress BUY | Hon. Gilbert Cisneros | $1,001 - $15,000 | source ↗ |
| 2026-06-15 | FDA Approvals & Recalls | FDA Approval | FDA approved HeartMate 3 Left Ventricular Assist System — ABBOTT MEDICAL | approval | source ↗ |
| 2026-06-15 | FDA Approvals & Recalls | FDA Approval | FDA approved TactiFlex Sensor Enabled Ablation Catheter — ABBOTT MEDICAL | approval | source ↗ |
| 2026-06-15 | FDA Approvals & Recalls | FDA Approval | FDA approved HeartMate II Left Ventricular Assist System — ABBOTT MEDICAL | approval | source ↗ |
| 2026-06-15 | FDA Approvals & Recalls | FDA Approval | FDA approved HeartMate 3 Left Ventricular Assist System — ABBOTT MEDICAL | approval | source ↗ |
| 2026-06-15 | FDA Approvals & Recalls | FDA Approval | FDA approved Aveir VR (LSCD111); DR Delivery Catheter (LSCD201) — ABBOTT MEDICAL | approval | source ↗ |
| 2026-06-12 | Financial News (Google News) | News | Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance | 3 | source ↗ |
| 2026-06-12 | Financial News (Google News) | News | Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance | 4 | source ↗ |
| 2026-06-12 | Financial News (Google News) | News | Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance | 8 | source ↗ |
| 2026-06-12 | U.S. House — Congressional Trades | Congress BUY | Hon. Richard Dean Dr McCormick | $1,001 - $15,000 | source ↗ |
| 2026-06-12 | Financial News (Google News) | News | Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance Singapore | 11 | source ↗ |
| 2026-06-12 | Financial News (Google News) | News | $ABT stock is down 3% today. Here's what we see in our data. - Quiver Quantitative | 14 | source ↗ |
| 2026-06-10 | Financial News (Google News) | News | Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance | 7 | source ↗ |
| 2026-06-08 | FDA Approvals & Recalls | FDA Approval | FDA approved Alinity m HR HPV — Abbott Molecular, Inc. | approval | source ↗ |
| 2026-06-08 | Financial News (Google News) | News | Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock - Yahoo Finance | 8 | source ↗ |
| 2026-06-08 | Financial News (Google News) | News | Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock - Yahoo Finance | 15 | source ↗ |
| 2026-06-08 | Financial News (Google News) | News | Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock - Yahoo Finance | 5 | source ↗ |
| 2026-05-27 | U.S. House — Congressional Trades | Congress SELL | Hon. Josh Gottheimer | $1,001 - $15,000 | source ↗ |
| 2026-05-15 | U.S. House — Congressional Trades | Congress SELL | Hon. Gilbert Cisneros | $1,001 - $15,000 | source ↗ |
| 2026-05-12 | U.S. House — Congressional Trades | Congress SELL | Hon. Julie Johnson | $1,001 - $15,000 | source ↗ |
| 2026-05-07 | SEC EDGAR Filings | Insider BUY | Stratton John G | $174K | source ↗ |
| 2026-05-07 | Insider Transactions (SEC Form 4) | Insider BUY | Stratton John G. bought 2,000 sh | $174K | source ↗ |
| 2026-05-07 | Financial News (Google News) | News | Is Abbott Laboratories (ABT) Now Offering Value After Recent Share Price Weakness? - Yahoo Finance | 4 | source ↗ |
| 2026-05-07 | Financial News (Google News) | News | Is Abbott Laboratories (ABT) Now Offering Value After Recent Share Price Weakness? - Yahoo Finance | 2 | source ↗ |
| 2026-04-27 | Insider Transactions (SEC Form 4) | Insider BUY | Starks Daniel J bought 10,000 sh | $927K | source ↗ |
| 2026-04-23 | Insider Transactions (SEC Form 4) | Insider BUY | Boudreau Philip P bought 2,200 sh | $201K | source ↗ |
| 2026-04-16 | U.S. House — Congressional Trades | Congress SELL | Hon. Richard W. Allen | $15,001 - $50,000 | source ↗ |
| 2026-03-27 | U.S. Senate — Congressional Trades | Congress SELL | Armstrong, Alan (Senator) | $15,001 - $50,000 | source ↗ |
| 2026-03-24 | U.S. House — Congressional Trades | Congress Trade | Hon. Laura Friedman | $1,001 - $15,000 | source ↗ |
| 2026-03-19 | U.S. House — Congressional Trades | Congress BUY | Hon. Richard Dean Dr McCormick | $1,001 - $15,000 | source ↗ |
| 2026-03-02 | Insider Transactions (SEC Form 4) | Insider SELL | Morrone Louis H sold 1,144 sh | $132K | source ↗ |
| 2026-03-02 | Insider Transactions (SEC Form 4) | Insider SELL | Mccoy John A. Jr sold 585 sh | $68K | source ↗ |
| 2026-03-02 | Insider Transactions (SEC Form 4) | Insider SELL | Cushman Elizabeth C sold 263 sh | $30K | source ↗ |
| 2026-03-02 | Insider Transactions (SEC Form 4) | Insider SELL | Salvadori Daniel Gesua Sive sold 885 sh | $102K | source ↗ |
| 2026-03-02 | Insider Transactions (SEC Form 4) | Insider SELL | Shroff Eric sold 709 sh | $82K | source ↗ |
| 2026-03-02 | Insider Transactions (SEC Form 4) | Insider SELL | Moreland Mary K sold 613 sh | $71K | source ↗ |
| 2026-02-04 | Insider Transactions (SEC Form 4) | Insider BUY | Starks Daniel J bought 10,000 sh | $1.1M | source ↗ |
| 2026-01-29 | Analyst Ratings (Upgrades/Downgrades) | Analyst Upgrade | Freedom Broker: Upgrade (Hold → Buy) | source ↗ | |
| 2026-01-23 | Insider Transactions (SEC Form 4) | Insider BUY | Ford Robert B. bought 18,800 sh | $2.0M | source ↗ |
| 2025-11-25 | Insider Transactions (SEC Form 4) | Insider SELL | Shroff Eric sold 1,586 sh | $203K | source ↗ |
| 2025-08-08 | Insider Transactions (SEC Form 4) | Insider SELL | Boudreau Philip P sold 5,550 sh | $747K | source ↗ |
Alt-Data Signal Hub · collected signals updated 2026-07-29 09:16 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice